MCMedicalCodingSoftware
C95.92

C95.92: Leukemia, unspecified, in relapse

Billable / specific codeICD-10-CM

C95.92 is a billable, specific ICD-10-CM code for leukemia, unspecified, in relapse. It is valid for submission on a claim.

Check C95.92 with the rest of the claim: free scrubber

Excludes1 inherited from the categories above C95.92

A category’s note binds every code beneath it.

Written on C95: Leukemia of unspecified cell type

  • personal history of leukemia (Z85.6)

Other codes that can never be billed with C95.92

Their own Excludes1 notes name this code, so the conflict is not listed above.

Risk adjustment

C95.92 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:

  • HCC 22 Bladder, Colorectal, and Other Cancers0.363 RAF

Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.

Medicare coverage

C95.92 is named in 29 Medicare coverage policies: 27 listing it as supporting medical necessity, and 2 listing it as NOT covered. Which one applies depends on your Medicare contractor.

  • A56462Billing and Coding: Erythropoiesis Stimulating Agents (ESA)not covered
  • A60435Billing and Coding: Erythropoiesis Stimulating Agents (ESA)not covered
  • A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
  • A52986Billing and Coding: Biomarkers for Oncology

Code history

Unchanged in every release from FY2024 to FY2027.

Other codes under C95.9

ICD-10-CMFY2027· effective October 1, 2026

Loaded directly from the CMS/NCHS ICD-10-CM public-domain release: see data sources and our editorial policy. If this page disagrees with the CMS tabular list, this page is wrong. Reference information for professional coders; not medical or billing advice.